CLARITAS HEALTHTECH LTD

Company Registration Number:
13756224 (England and Wales)

Unaudited abridged accounts for the year ended 31 March 2025

Period of accounts

Start date: 01 April 2024

End date: 31 March 2025

CLARITAS HEALTHTECH LTD

Contents of the Financial Statements

for the Period Ended 31 March 2025

Balance sheet
Notes

CLARITAS HEALTHTECH LTD

Balance sheet

As at 31 March 2025


Notes
2025
2024


£
£
Fixed assets
Tangible assets: 3 3,956 6,914
Total fixed assets: 3,956 6,914
Current assets
Debtors:   33,657 11,209
Cash at bank and in hand: 491,893 474,688
Investments:   129,242 108,845
Total current assets: 654,792 594,742
Creditors: amounts falling due within one year:   (33,365) (76,071)
Net current assets (liabilities): 621,427 518,671
Total assets less current liabilities: 625,383 525,585
Creditors: amounts falling due after more than one year:   (1,025,872) (758,779)
Total net assets (liabilities): (400,489) (233,194)
Capital and reserves
Called up share capital: 1,904,411 1,904,411
Profit and loss account: (2,304,900) (2,137,605)
Shareholders funds: (400,489) (233,194)

The notes form part of these financial statements

CLARITAS HEALTHTECH LTD

Balance sheet statements

For the year ending 31 March 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 16 December 2025
and signed on behalf of the board by:

Name: Chetan Baxi
Status: Director

The notes form part of these financial statements

CLARITAS HEALTHTECH LTD

Notes to the Financial Statements

for the Period Ended 31 March 2025

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

Tangible fixed assets and depreciation policy

Depreciation is charged to write off the cost of assets over their estimated useful lives, as follows: Asset Class and Depreciation Method Office equipment (eg laptops): 3 years on Cost Medical equipment (eg scopes): 3 years on Cost

CLARITAS HEALTHTECH LTD

Notes to the Financial Statements

for the Period Ended 31 March 2025

2. Employees

2025 2024
Average number of employees during the period 8 8

CLARITAS HEALTHTECH LTD

Notes to the Financial Statements

for the Period Ended 31 March 2025

3. Tangible Assets

Total
Cost £
At 01 April 2024 8,874
At 31 March 2025 8,874
Depreciation
At 01 April 2024 1,960
Charge for year 2,958
At 31 March 2025 4,918
Net book value
At 31 March 2025 3,956
At 31 March 2024 6,914

CLARITAS HEALTHTECH LTD

Notes to the Financial Statements

for the Period Ended 31 March 2025

4. Financial commitments

Contingent Liabilities & Capital Commitments: There were no known contingent liabilities or major capital commitments as of 31 March 2025